Patent · US Active

Oxytocin compositions and methods of use

US11266711B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

Elgan Pharma Ltd · IL

Inventors

Dean Carson · Palo Alto, US
Marc Pentopoulos · Palo Alto, US

Key dates

Filing date	Apr 8, 2019
Grant date	Mar 8, 2022
Priority date	—
Expiry date	Apr 8, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are oxytocin compositions having a therapeutically effective amount of oxytocin, an analog or derivative of oxytocin, or an oxytocin receptor agonist for the treatment of neonatal abstinence syndrome (“NAS”) in a subject. Also disclosed are methods for the treatment of NAS by administering a therapeutically effective amount of oxytocin, an analog or derivative of oxytocin, or an oxytocin receptor agonist to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.